Kevin J Friesen1, Cornelius Woelk1, Shawn Bugden2. 1. College of Pharmacy (Friesen, Bugden) Faculty of Health Sciences, University of Manitoba; Department of Family Medicine (Woelk), College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Man. 2. College of Pharmacy (Friesen, Bugden) Faculty of Health Sciences, University of Manitoba; Department of Family Medicine (Woelk), College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Man. shawn.bugden@umanitoba.ca.
Abstract
BACKGROUND: Although a convenient opioid delivery system, transdermal fentanyl patches have caused several deaths and resulted in safety warnings reminding prescribers that fentanyl patches should be prescribed only for patients who have adequate prior exposure to opioids. We conducted a longitudinal analysis of the safety of fentanyl initiation by examining past opioid exposure among patients newly prescribed fentanyl patches. METHODS: We identified all patients in the province of Manitoba who were newly prescribed fentanyl patches between Apr. 1, 2001, and Mar. 31, 2013. We converted all prior opioid use to oral morphine equivalents and determined the average daily dose in the 7-30 days before initial fentanyl patch use. Fentanyl initiation was considered unsafe if the patient's pre-fentanyl opioid exposure was below the recommended level. RESULTS: We identified 11 063 patients who began using fentanyl patches during the study period. Overall, fentanyl initiation was deemed unsafe in 74.1% of cases because the patient's prior opioid exposure was inadequate. Women and patients 65 years of age and older were more likely than men and younger patients, respectively, to have inadequate prior opioid exposure (p < 0.001 for each comparison). The proportion of patients who had unsafe prescriptions for fentanyl patches decreased significantly over the study period, from 87.0% in 2001 to 50.0% in 2012 (p < 0.001). INTERPRETATION: The safety of fentanyl initiation improved over the study period, but still half of fentanyl patch prescriptions were written for patients with inadequate prior opioid exposure. Review of prior opioid exposure may be a simple but important way to improve the safe use of fentanyl patches.
BACKGROUND: Although a convenient opioid delivery system, transdermal fentanyl patches have caused several deaths and resulted in safety warnings reminding prescribers that fentanyl patches should be prescribed only for patients who have adequate prior exposure to opioids. We conducted a longitudinal analysis of the safety of fentanyl initiation by examining past opioid exposure among patients newly prescribed fentanyl patches. METHODS: We identified all patients in the province of Manitoba who were newly prescribed fentanyl patches between Apr. 1, 2001, and Mar. 31, 2013. We converted all prior opioid use to oral morphine equivalents and determined the average daily dose in the 7-30 days before initial fentanyl patch use. Fentanyl initiation was considered unsafe if the patient's pre-fentanyl opioid exposure was below the recommended level. RESULTS: We identified 11 063 patients who began using fentanyl patches during the study period. Overall, fentanyl initiation was deemed unsafe in 74.1% of cases because the patient's prior opioid exposure was inadequate. Women and patients 65 years of age and older were more likely than men and younger patients, respectively, to have inadequate prior opioid exposure (p < 0.001 for each comparison). The proportion of patients who had unsafe prescriptions for fentanyl patches decreased significantly over the study period, from 87.0% in 2001 to 50.0% in 2012 (p < 0.001). INTERPRETATION: The safety of fentanyl initiation improved over the study period, but still half of fentanyl patch prescriptions were written for patients with inadequate prior opioid exposure. Review of prior opioid exposure may be a simple but important way to improve the safe use of fentanyl patches.
Authors: Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink Journal: CMAJ Date: 2009-12-07 Impact factor: 8.262
Authors: Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Irfan A Dhalla; David N Juurlink Journal: Can Fam Physician Date: 2014-09 Impact factor: 3.275
Authors: Carla Ripamonti; Elena Fagnoni; Tiziana Campa; Cinzia Brunelli; Franco De Conno Journal: Support Care Cancer Date: 2006-02-17 Impact factor: 3.603
Authors: Ejaz Cheema; Khalil McGuinness; Muhammad Abdul Hadi; Vibhu Paudyal; Mohammed Hassan Elnaem; Abdullah A Alhifany; Mahmoud E Elrggal; Abdullah Al Hamid Journal: J Pain Res Date: 2020-12-07 Impact factor: 3.133
Authors: Molly Moore Jeffery; Christine E Chaisson; Christopher Hane; Louis Rumanes; Jamie Tucker; Lillian Hang; Rozalina McCoy; Catherine L Chen; Mark C Bicket; W Michael Hooten; Marc Larochelle; William C Becker; Cynthia Kornegay; Judith A Racoosin; Darshak Sanghavi Journal: JAMA Netw Open Date: 2020-04-01